Dallas, Texas (PRWEB) July 27, 2014
One of the emerging trends I the market is the increasing demand for genomics products from the Asia Pacific (APAC) region. The Diagnostics industry, in countries such as China and India, is expected to generate high demand for genomics solutions, thereby contributing to market growth.
Analysts forecast the Global Genomics market will grow at a CAGR of 11.21 percent over the period 2013-2018. According to the report, the most important driver of the market is an increase in the demand for consumables. The growing adoption of genetic testing for various applications, especially in regions such as the APAC, and an increase in genetic testing volumes in North America and Western Europe is increasing the demand for consumables.
This report covers the present scenario and the growth prospects of the Global Genomics market for the period 2014-2018. To arrive at a ranking of the leading vendors of the market, and to calculate the market size, the report considers the revenue generated by vendors through the sales of instruments, consumables, and services for genomics. It also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Genomics market. The report also provides data on the different segments of the Global Genomics market, which are based on the following criteria: product, end-user, and geography. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
Global Genomics Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and EMEA and APAC regions.
Purchase Single User License of the Report for US $2500 at http://www.sandlerresearch.org/purchase?rname=19826.
The recognizes the following companies as the key players in the Global Genomics Market: F. Hoffmann-La Roche Ltd., Illumina Inc., Life Technologies Corp. and Qiagen NV.
Other Prominent Vendors in this market are Affymetrix, Agilent Technologies, BGI,Bio-Rad Laboratories, Biotage, Caliper Life Sciences, Cepheid, Cytocell, Enzo Biochem, Exiqon, GE Healthcare, Genisphere, Genomatix Software, Gen-Probe, Harvard Bioscience, Luminex.
Key Market Driver
- Increase in Demand for Consumables
Key Market Challenge
- Increasing Market Consolidation
Key Market Trend
- Increasing Demand from the APAC Region
Pharmacogenomics involves the study of genetic variations that influence an individual's response to drugs. It is one of the crucial steps of personalized treatment. It has many applications in clinical practices, including the detection of viral drug resistance, targeted therapy, and the minimization of the adverse effects of drugs. The FDA also encourages the use of pharmacogenomics for the drug development process. Pharmacogenomics is a major step in clinical trials to study the toxicity and side effects of the drug.
Analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018. According to the report, the Global SNP Genotyping and Analysis market is driven by several factors. Advancement in SNP genotyping and analysis technology is one of the major drivers. The improved accuracy, high sensitivity, and better diagnostic speed of SNP genotyping tools drive the growth of the Global SNP Genotyping and Analysis market.
This report covers the present scenario and the growth prospects of the Global SNP Genotyping and Analysis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of SNP analysis systems, consumables, and services used in SNP analysis. In addition, predominant technologies used for SNP genotyping and analysis, such as SNP gene chips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight, are considered in the scope of the report.
The report recognizes the following companies as the key players in the Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market: Affymetrix Inc., Illumina Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Douglas Scientific Llc., Fluidigm Corp., Luminex Corp., PREMIER Biosoft Intl., Promega Corp, Qiagen N. V., Sequenom Inc., WaferGen Biosystems Inc.
Purchase single user license of the report for US $2500 at http://www.sandlerresearch.org/purchase?rname=19842.
- Advances in Technology
- Reimbursement Complications
- Increasing Pharmacogenomics Study
Other Related Report:
Global Genomics and Proteomics Analytical Instruments Market 2014-2018: The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing.
Global Cell Culture Market 2014-2018: Analysts forecast the Global Cell Culture market will grow at a CAGR of 10.27 percent over the period 2013-2018.
Explore other new reports on Biotechnology Market.
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.